Sumitomo Pharma Co Ltd (TSE:4506)
円 336 -19 (-5.35%) Market Cap: 133.49 Bil Enterprise Value: 516.24 Bil PE Ratio: 0 PB Ratio: 0.85 GF Score: 49/100

Q1 2021 Sumitomo Dainippon Pharma Co Ltd Earnings Call Transcript

Jul 30, 2020 / NTS GMT
Release Date Price: 円1328 (-0.67%)
Operator

Thank you for joining the earnings call for Sumitomo Dainippon Pharma. We will be presenting the financial results for the first quarter and development status update. Attendees from Sumitomo are Toru Kimura, Chief Scientific Officer; and Kashima-san from Finance and Accounting. Please refer to the slide deck on the corporate website. Please note that the conference call will be recorded and posted on the website.

Kashima-san will be giving the presentation first.

Hisayoshi Kashima
Sumitomo Dainippon Pharma Co., Ltd. - Senior Director & Corporate Controller

I would like to explain the first quarter financial results and development pipeline updates. Please look at Slide 3. This shows financial results for the first quarter. The numbers are shown on IFRS core basis. The revenues were JPY 133.9 billion, up by JPY 16.4 billion from the same period last year. The China segment declined, while Japan and North America segment increased revenues. SG&A expenses exceeded last year due to increased costs from Sumitovant consolidation, while sales promotion

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot